-UNIVERSITY OF HELSINKI: Personalized nanovaccines are safe, well tolerated, and have an effect in melanoma

Press/Media: Press / Media

Period14 Jun 2019

Media coverage

1

Media coverage

  • Title-UNIVERSITY OF HELSINKI: Personalized nanovaccines are safe, well tolerated, and have an effect in melanoma
    Media name/outletENP Newswire
    CountryUnited Kingdom
    Date14/06/2019
    PersonsFlavia Fontana
View all 1
View less